OAC
ELTX icon

OMERS Administration Corp’s Elicio Therapeutics ELTX Stock Holding History

OMERS Administration Corp’s Portfolio ELTX Stock Details ELTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,700
Closed -$114K – 994
2026
Q1 		$114K Sell
10,700
-12,800
-54% -$124K ﹤0.01% 998
2025
Q4 		$187K Buy
+23,500
New +$213K ﹤0.01% 920

Other funds holding ELTX

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

OMERS Administration Corp's ELTX Position: Q2 2026 in Review

OMERS Administration Corp sold out of Elicio Therapeutics (ELTX) in Q2 2026, closing a stake of 10,700 shares — an estimated $114K sold.

OMERS Administration Corp first reported a position in ELTX in Q4 2025 and held it in 2 quarters. The position peaked at $187K in Q4 2025. 48 funds tracked by Wall St. Rank hold ELTX as of Q2 2026.

  • OMERS Administration Corp reported no remaining Elicio Therapeutics position as of Q2 2026 after selling out during the quarter.
  • OMERS Administration Corp sold 10,700 Elicio Therapeutics shares in Q2 2026, an estimated $114K.
  • OMERS Administration Corp first reported a position in Elicio Therapeutics in Q4 2025 and held it in 2 quarters.
  • OMERS Administration Corp's Elicio Therapeutics position peaked at $187K in Q4 2025.
  • 48 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.